The invention provides a new method for treating disorders associated with activation of the Notch signal transduction pathway comprising administering an effective amount of a compound of Formula (I), in free form or in a pharmaceutically acceptable salt form or in the form of a pharmaceutically acceptable solvate of the compound or the salt, to a human or animal patient in need thereof.
申请公布号
WO2007104933(A8)
申请公布日期
2008.09.18
申请号
WO2007GB00813
申请日期
2007.03.09
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;HUDSON, KEVIN;LAING, NAOMI;LEWIS, PAULA